Market Size of Organ Care Systems (OCS) Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 9.10 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Organ Care Systems (OCS) Market Analysis
The organ care system market studied is anticipated to grow with a CAGR of 9.1% during the forecast period.
The sudden outbreak of COVID-19 had a significant impact on the market. This was mainly due to the reduction of organ donation and transplantation procedures due to the cancellation of elective procedures to curb the pandemic infection. The article published in Springer in December 2021 mentioned a 21% reduction in organ donation and a 59% reduction in transplants. The source also noted that 59% of living donor kidney transplant programs suspended the evaluation of new donors due to the COVID-19 pandemic. Such reduction in organ donations and transplantation during the pandemic significantly impacted the market growth. However, the relaxation of strict regulations during the post-pandemic increased organ donations and transplant surgeries, thereby contributing to the market's growth over the forecast period.
Some significant market growth factors are the increased incidence of various chronic disorders resulting in organ failures, along with a high volume of organ transplantation surgeries. The rising technological developments are also expected to contribute to the market's growth.
Similarly, according to the data published by the British Heart Foundation in August 2022, in the United Kingdom, over 7.6 million people survived heart or circulatory disease in 2021. The World Kidney day data published in March 2022 mentioned that about 1 in 10 people worldwide have chronic kidney disease. The prevalence of various conditions resulting in organ transplantation is expected to contribute to the market's growth. Additionally, the high organ transplantation volume is expected to drive market growth. For instance, the data published by the print in May 2022 mentioned that nearly 17,000 to 18,000 solid organ transplants are performed in India each year.
Furthermore, the increasing product approvals and launches by various key market players are also expected to contribute to the market's growth. In December 2021, OrganOx received the United States FDA's premarket approval for its metra system. The metra is a fully automated NMP device for preserving and transporting donor livers destined for transplantation.
Thus, the increasing demand for organ transplantation surgeries and product approvals and developments are expected to contribute to the market's growth over the forecast period.
